uconn health

Proposal Development Services Offered

Please click to expand the sections below in order to learn more about the Research Development Services (RDS) available.

RDS services are supported by the OVPR and are open to all UConn/UConn Health free of charge.

Consultation to determine fit with funding opportunity

What we provide: A phone call or video chat to discuss how your proposed research meets the described funding opportunity and the funder’s overall priorities, as well as margin comments on your document to enhance competitiveness. We may also suggest that you contact a funding agency program officer or other experts and can provide suggestions on what to say during this discussion.

What you provide: The funding opportunity you are interested in applying to (website link or PDF document) and a one-page concept paper or specific aims document describing your research and how you will respond to the funding opportunity.

Timeline: This consultation requires a minimum of one week. We recommend that this step is completed several months before the proposal due date.

Brief review of an early draft

What we provide: High-level comments on narrative structure and content. Changes will be tracked and notes made in the margin of your document. Comments may relate to alignment with funder objectives, the logical flow of the narrative, completeness, and general grantsmanship suggestions.

What you provide: A completed draft of the project narrative or description and the funding opportunity you are interested in applying to (website link or PDF document). For any resubmissions/revisions, please also provide the previous submission and any reviews or comments from the funder.

Timeline: This brief review requires a minimum of two weeks. We recommend that the review is completed one to two months before the proposal due date to allow time for modifications.

In-depth review of a completed draft

What we provide: High-level comments on narrative structure and content. Changes will be tracked and notes made in the margin of your document. Comments may relate to alignment with funder objectives, the logical flow of the narrative, completeness, and general grantsmanship suggestions. Review of written supporting documents if provided by the PI. Line edits for improved wording, grammatical structure, etc. are available upon request, scheduling permitting.

What you provide: A completed draft of the project narrative or description, the project abstract or summary, and other supporting documentation you would like to have reviewed. Please also provide the funding opportunity you are interested in applying to (website link or PDF document). For any resubmissions/revisions, please also provide the previous submission and any reviews or comments from the funder.

Timeline:  High-level comments on narrative structure and content should take place 1-2 months before the proposal is due. Follow-up review with line edits should take place within three weeks of proposal submission.

Mid-scale proposal development support ($1M-$5M)

What we can provide:

  1. Planning support – review of funding opportunity (proposal requirements), analysis of funding agency expectations, establishing proposal development timeline
  2. Writing and editing – document review, writing support as needed (generally non-scientific sections)
  3. Document management – coordinate with PI, research team, and budget and administrative support staff

What you provide: The funding opportunity you are interested in applying to (website link or PDF document), your anticipated team of PIs/personnel, and a one- to two-page concept paper describing your research and how you will respond to the funding opportunity.

Timeline: This service should be requested at least 3-6 months prior to the proposal due date.

Large and complex proposal development support ($5M+)

What we can provide:

  1. Planning support – review of funding opportunity (proposal requirements), analysis of funding agency expectations, establishing proposal development timeline
  2. Organizational – coordination among research team, external partners, administrative staff, etc.; tracking progress towards proposal completion; keeping process on track.
  3. Writing and editing – document review, writing support as needed (generally non-scientific sections)
  4. Document management – coordinate with PI, research team, and budget and administrative support staff

What you provide: The funding opportunity you are interested in applying to (website link or PDF document), your anticipated team of PIs/personnel, and a one- to two-page concept paper describing your research and how you will respond to the funding opportunity.

Timeline: This service should be requested at least 6 months prior to the proposal due date.

Now available! – Proposal Proofreading

What we provide:  A full read-through of the proposal by a member of our proofreading pool to identify and correct typos, formatting errors, or minor grammatical issues.  Track changes will be used to allow the investigator an opportunity to review all changes made prior to the proposal moving forward.

What you provide: A final version of all proposal documents the investigator would like reviewed.  Documents provided should be as close to a final polished form as possible; the proofreading service is intended to give proposal documents a final review, not more substantive revision and editing.

Timeline: Proposal proofreading requires a minimum of 3-5 business days. We recommend that this step is requested no later than 10 business days before the proposal due date to the sponsor (5 business days prior to the SPS Pre-award internal deadline).

 

Research Development Services (RDS): Proposal Development Services Overview

Overview

As a University, we’ve committed to work together to substantially grow UConn/UConn Health’s capacity for high-level research, scholarship, and creative endeavors.  As part of its Research Development (RD) efforts, the Office of the Vice President for Research now offers proposal development services to increase the competitiveness of proposals UConn/UConn Health investigators submit to funders.  The services offered include consultation, brief and in depth proposal reviews, and large and complex proposal support.  They are open to all UConn/UConn Health faculty free of charge.

Proposal development services build on the success of OVPR RD initiatives such as grantwriting training and seed funding programs by providing grantwriting support, including grantsmanship reviews, proposal editing, and project management support for large and complex proposals.  These services are designed to ensure that high-quality science and scholarship proposed by UConn investigators can be as competitive as possible.

To learn more about the role and mission of our Research Development Services team, the services we offer, and UConn’s priority areas for research growth, please explore our website.

RDS Proposal Development Mission

The mission of the Research Development Services (RDS) team is to support the research growth of the University by increasing the competitiveness of proposals submitted by UConn/UConn Health investigators seeking external funding.  We prioritize support for proposals that align with one or more of the University’s strategic priorities.  We aim to provide targeted support of the proposal development process, using our skills and experience to extend and refine the capacity of UConn/UConn Health faculty to develop and submit larger and more compelling proposals.  Our goal is to provide high-level support in our areas of expertise, including:

  • Technical writing and editing
  • Interpreting and applying the requirements and proposal conventions of major funders, funding programs, and funding opportunity announcements
  • Knowledge of grantsmanship strategies
  • Project Management
  • Familiarity with UConn/UConn Health research capacities, faculty, resources, and systems

The role of the RDS team in the proposal development process

Investigators are the driving force behind the writing and submission of grant proposals.  Without the scientific/scholarly expertise, ambition, and dedicated work of PIs, proposals don’t get done!  However, we also know that PIs rarely work alone as they seek external funding; proposal preparation and submission is usually a team effort.  Let’s take a look at the different players in the grantseeking process and see how research development fits in.

Scientific/Scholarly Team: The PI(s) and their team(s) of collaborators are the creative center of the grantwriting process.  Together, they set the direction of the work, draft technical sections of the proposal, and work to ensure that the research proposed is of high scientific/scholarly merit, consulting when necessary with other disciplinary experts.

Budget and Administrative Support: The staff in the investigators’ departments, school/college office, or in OVPR Faculty Services are essential members of the team who assist with the preparation of budgets, proposal assembly, and other administrative aspects of the proposal development process.

SPS Pre-award: The staff in Sponsored Program Services, while not involved in the creation of a proposal, are responsible for conducting a final compliance review and certification of the proposal, and in most cases are responsible for its final submission to the sponsor.

Research Development Services Support: The Research Development Services team provides an additional layer of proposal development support, filling gaps between what the PI team is responsible for and what the budget and administrative support team is responsible for.

  • While not necessarily scientific/scholarly experts in the PI(s) field(s), the RDS team are experts in writing, editing, and organization and in the requirements/expectations of funders. The RDS team can join with the PI team to help produce proposal narratives that are clearer, more compelling, and better aligned with funder expectations—i.e. proposals that are more fundable!
  • For larger and more complex proposals, the RDS team can provide a project management function for the proposal development process. RDS can help set and manage timelines, facilitate group interactions, assist with document management, and help coordinate connections among the differing areas of budget and administrative support that may be involved with a large/complex proposal.

UConn COVID-19 Research Seed Funding (COVID-RSF2) Program

Note: The guidelines below are for the second cycle of COVID-RSF funding.  Click here to for the first cycle guidelines.  The COVID-RSF program is now closed and no additional funding cycles are anticipated.

Purpose

COVID-RSF (Rapid Start Funding) and COVID-RSF2 (Research Seed Funding) are initiatives of the Office of the Vice President for Research (OVPR) that support the development of promising projects related to COVID-19.  Given the enthusiastic and high-quality response to the first COVID-RSF cycle (37 white papers were received, resulting in 5 awards of up to $50K each), Vice President Maric has allocated additional funds to support COVID-19 related research.  The OVPR anticipates offering an additional 10 awards of up to $10K each.

This new competition, COVID-RSF2, expands the scope of the previous call to include longer-term projects and additional topics.  In addition to seeking mature projects promising very near-term impact on the detection, diagnosis, treatment, and prevention of COVID-19, we also welcome proposals for earlier-stage COVID-19 seed projects, small scale pilot projects, projects related to the social and medical impact of COVID-19, and other related topics.

Applications will be collected and rapidly reviewed in mid-to-late October, with the goal releasing funding by early November.

 

Timeline:

  • Proposals (brief whitepapers, plus budget and biosketches) due Friday, October 16, 2020 by 12 noon.
  • Submissions should be made via the UConn Quest portal.
  • Award notices expected by October 30.  Award setup will begin immediate after notice, pending the completion of compliance review.

 

Program/Award Details:

  • Up to 10 awards of up to $10K will be made
  • Standard award period will be November 2020 through December 31, 2021.

 

Eligibility

The COVID-RSF2 Program is available to UConn / UConn Health faculty members, within the following parameters:

  • UConn Primary Appointment: PIs must be full-time faculty whose primary appointment is at UConn/UConn Health. Investigators with primary appointments to CCMC, Jackson Labs, TIP companies, or other institutions are not eligible to lead projects, but they may be named as Co-PIs, collaborators, or consultants on an eligible PI’s project.  Proposals that include external Co-PIs should be careful to describe how responsibility for the project will be divided between institutions, and ideally they will include cost-sharing commitments from external partners
  • Effort and Salary: Although no minimum effort level is required for COVID-RSF2 projects, a UConn/UConn Health PI/Co-PI must have institutionally-funded research time available during the award period or address in the application how they will handle the time commitment required by the project. PIs/Co-PIs must each make significant and distinct intellectual contributions to the design and direction of the project. Generally speaking, awards are only available to UConn/UConn Health tenure-track and clinical faculty and in-Residence faculty at the Storrs/Regional campuses. UCH in-residence faculty and research faculty are not eligible to apply as PI but can be named as Co-PIs, collaborators, or consultants on an eligible PI’s project.
  • Application Limits: Eligible faculty may submit multiple proposals, so long as each are scientifically distinct. Investigators may serve as collaborator on multiple projects.
  • COVID-RSF Resubmissions:  Faculty who submitted white papers for the previous COVID-RSF mechanism are eligible to resubmit if they wish, provided the white papers and budgets are appropriately reconfigured to be commensurate with a $10K award.

Proposal Guidelines

Proposals for COVID-RSF2 Awards should contain the following elements and follow the structure and guidelines indicated.  All length guidelines assume 1” margins, 11-12pt fonts, single spacing and single side pages.

  • Cover Page: Title of Project, Principal investigator(s) with contact information, List of other team members, Specific funding mechanism targeted, Target submission date
  • White Paper: Briefly describe the project, how it will be conducted, and anticipated outcomes. White papers should address the following areas and should not exceed 2-3 pages in length:
    • Core Research Questions to be addressed and their significance
    • Currently available resources and personnel and how they will support the project
    • Proposed activities under COVID-RSF2 Award and how they will advance the project towards the goal of impacting the fight against COVID-19.  If you have a specific funding mechanism in mind for follow-up funding, also address how the work under this award will improve competitiveness for that mechanism.
  • Budget describing and justifying use of COVID-RSF2 funds.  You can use this budget template.
  • Biosketches / CVs for all PIs and Co-PIs: Please include an updated biosketch consistent with NIH (max 5 pg)/NSF (max 2 pg) format.  If your field is not typically funded by NSF/NIH, please include a brief CV following your discipline’s conventions.
  • NSF/NIH-style Letters of support from any facilities providing support during the COVID-RSF award period

Budget Guidelines

Below are general guidelines regarding allowable/unallowable costs that are consistent with other OVPR internal funding opportunities.  If you have a budget need that does not fit within these guidelines, you may include it, but we ask that you provide strong justification in support of the request.  You can use this budget template.

  • Allowable costs include: graduate research assistant salary, Postdoc or other Research Assistant salary, Undergraduate Researcher salary, Course buyouts (approval letter from Department Head required), Fringe costs, equipment purchases, travel to conduct research or meet with collaborators (Provost approval may be required), materials and supplies, participant support costs, animal/animal care costs, contractual services
  • Unallowable costs include: faculty member / professional staff salaries, clerical or administrative personnel salaries, including personnel whose primary purpose is to explore funding sources and/or prepare grant applications; service/maintenance contracts on equipment; laboratory renovations, or other infrastructure renovations; institutional memberships in professional organizations; travel to professional meetings to present the results of the research; travel to explore extramural funding opportunities; costs associated with the publication of results of the research, including page charges, purchase of reprints, or journal costs.

Review Criteria

  • Significance/Importance – Does this project address a significant scientific question / technical problem?
  • Innovation/Novelty – Does this project approach the problem in a new/innovative way?
  • Feasibility of Approach – Does this project have a clear and methodologically sound approach?  Is the plan of work described likely to succeed?
  • Environment/Resources – Are available resources/facilities sufficient to successfully complete the work?
  • PI/Team qualifications – Who will be working on this project, and how are they uniquely suited to accomplish this work?  Does the team have a strong track record of external grant success?
  • Outcome – Does the project promise to produce significant value / high impact?
  • Assessment – Does the project have a reasonable plan for measuring and determining success?
  • Budget – Are funds to be used efficiently and effectively to achieve project goals?

Post-Award Considerations and Reporting

  • Reporting requirements: PIs will need to prepare a brief report summarizing project progress at the conclusion of the project.
  • Further reports on project outcomes may be requested in the future to track return on investment.

Program Contacts

    • Administrative contact: Matt Mroz, PhD, OVPR Internal Funding Coordinator. research@uconn.edu;
    • Program Director: Mark Aindow, PhD, Executive Director for Innovation, External Engagement, and Industry Relations. m.aindow@uconn.edu

UConn COVID-19 Rapid Start Funding (COVID-RSF) Program

Note: The guidelines below are for the first cycle of COVID-RSF funding, which is now closed.  Click here for updated and expanded COVID-RSF2 (COVID-19 Research Seed Fund) guidelines.

 

Purpose

COVID-RSF is an initiative of the Office of the Vice President for Research (OVPR) that supports the development of promising projects related to COVID-19.  Many funding agencies have responded to the pandemic by creating emergency/rapid funding mechanisms that address key scientific problems related to the detection, diagnosis, treatment, and prevention of this disease.  A recent and notable example is the NIH RADx-rad program, which seeks to advance capabilities related to COVID-19 testing.

This internal funding mechanism seeks to identify and support novel technologies and approaches with strong potential to be competitive for emergency funding opportunities addressing COVID-19.  Proposals should be able to make a compelling case that the technology/approach is unique and can have a significant impact on COVID-19 related challenges in the near term.  Given the rapidly-changing nature of the COVID-19 funding landscape, projects with the potential for this kind of impact will be considered regardless of whether a specific external funding opportunity currently addresses it.

COVID-RSF seeks proposals for potentially high-impact projects that are ready to launch in a short period of time.  As such, early-stage seed projects or other developmental work will not be competitive.  Applications will be collected and rapidly reviewed in early September, with funding to be released by October 1.  It is expected that COVID-RSF funding will be used to support a short ramp-up period for these highly-competitive projects while they are being submitted and considered for rapid-response external funding.

To give a sense of the NIH’s current interests related to COVID-19, some of the topics addressed by the recent RADx-rad program include:

  1. Wastewater detection of SARS-COV-2 (COVID-19)
  2. Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2
  3. Chemosensory Testing as a COVID-19 Screening Tool
  4. Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds)
  5. Multimodal COVID-19 surveillance methods for High Risk Populations in densely populated facilities
  6. Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity
  7. Automatic detection and tracing of SARS-COV-2
  8. RADx-rad will also have a Data Coordination Center (DCC) which will provide management, direction, and overall coordination across RADx-rad awardees in areas such as data sharing, data management standards, terminologies, and common data elements.

Other topics from across all disciplines will also be considered, so long as they have potential to make an immediate impact on the detection, diagnosis, treatment, and prevention of COVID-19.

 Timeline:

  • Proposals (brief whitepapers, plus budget and biosketches) due Friday, Sept 11 2020 by 12 noon. Program now closed.
  • Submissions should be made via the UConn Quest portal.
  • Award notices expected by Sept 18.  Award setup will begin immediate after notice, pending the completion of compliance review.

Program/Award Details:

  • Several awards of up to $50K will be made
  • As these are rapid-response grants, it is expected that projects would spin up quickly following award and the scope-of-work completed within a few months.  Projects with a scope longer than 6 months are strongly discouraged.

 

Eligibility

The COVID-RSF Program is available to UConn / UConn Health faculty members, within the following parameters:

  • UConn Primary Appointment: PIs must be full-time faculty whose primary appointment is at UConn/UConn Health. Investigators with primary appointments to CCMC, Jackson Labs, TIP companies, or other institutions are not eligible to lead projects, but they may be named as Co-PIs, collaborators, or consultants on an eligible PI’s project.  Proposals that include external Co-PIs should be careful to describe how responsibility for the project will be divided between institutions, and ideally they will include cost-sharing commitments from external partners
  • Effort and Salary: Although no minimum effort level is required for COVID-RSF projects, a UConn/UConn Health PI/Co-PI must have departmental research time available during the award period or address in the application how they will handle the time commitment required by the project. PIs/Co-PIs must each make significant and distinct intellectual contributions to the design and direction of the project. Generally speaking, awards are only available to UConn/UConn Health tenure-track and clinical faculty and in-Residence faculty at the Storrs/Regional campuses. UCH in-residence faculty and research faculty are not eligible to apply as PI but can be named as Co-PIs, collaborators, or consultants on an eligible PI’s project.
  • Application Limits: Eligible faculty may submit multiple proposals, so long as each are scientifically distinct. Investigators may serve as collaborator on multiple projects.

Proposal Guidelines

Proposals for COVID-RSF Awards should contain the following elements and follow the structure and guidelines indicated.  All length guidelines assume 1” margins, 11-12pt fonts, single spacing and single side pages.

  • Cover Page: Title of Project, Principal investigator(s) with contact information, List of other team members, Specific funding mechanism targeted, Target submission date
  • White Paper: Briefly describe the project, how it will be conducted, and anticipated outcomes. White papers should address the following areas and should not exceed 2-3 pages in length:
    • Core Research Questions to be addressed and their significance
    • Currently available resources and personnel and how they will support the project
    • Proposed activities under COVID-RSF Award and how they will advance the project towards the goal of impacting the fight against COVID-19.  If you have a specific funding mechanism in mind for follow-up funding, also address how the work under this award will improve competitiveness for that mechanism.
  • Budget describing and justifying use of COVID-RSF funds.  You can use this budget template.
  • Biosketches / CVs for all PIs and Co-PIs: Please include an updated biosketch consistent with NIH (max 5 pg)/NSF (max 2 pg) format.  If your field is not typically funded by NSF/NIH, please include a brief CV following your discipline’s conventions.
  • NSF/NIH-style Letters of support from any facilities providing support during the COVID-RSF award period

Budget Guidelines

Below are general guidelines regarding allowable/unallowable costs that are consistent with other OVPR internal funding opportunities.  Given the unique nature of the COVID-RSF mechanism, we understand that these guidelines may not include all budget items that are necessary to enhance competitiveness for your targeted external mechanism.  If you have a budget need that does not fit within these guidelines, you may include it, but we ask that you provide strong justification in support of the request.  You can use this budget template.

  • Allowable costs include: graduate research assistant salary, Postdoc or other Research Assistant salary, Undergraduate Researcher salary, Course buyouts (approval letter from Department Head required), Fringe costs, equipment purchases, travel to conduct research or meet with collaborators (Provost approval may be required), materials and supplies, participant support costs, animal/animal care costs, contractual services
  • Unallowable costs include: faculty member salaries, clerical or administrative personnel salaries, including personnel whose primary purpose is to explore funding sources and/or prepare grant applications; service/maintenance contracts on equipment; laboratory renovations, or other infrastructure renovations; institutional memberships in professional organizations; travel to professional meetings to present the results of the research; travel to explore extramural funding opportunities; costs associated with the publication of results of the research, including page charges, purchase of reprints, or journal costs.

Review Criteria

  • Timing – Is the project capable of spinning up immediately?
  • Significance/Importance – Does this project address a significant scientific question / technical problem?
  • Innovation/Novelty – Does this project approach the problem in a new/innovative way?
  • Feasibility of Approach – Does this project have a clear and methodologically sound approach?  Is the plan of work described likely to succeed?
  • Environment/Resources – Are available resources/facilities sufficient to successfully complete the work?
  • PI/Team qualifications – Who will be working on this project, and how are they uniquely suited to accomplish this work?  Does the team have a strong track record of external grant success?
  • Outcome – Does the project promise to produce significant value / high impact?
  • Assessment – Does the project have a reasonable plan for measuring and determining success?
  • Budget – Are funds to be used efficiently and effectively to achieve project goals?

Post-Award Considerations and Reporting

  • Reporting requirements: PIs will need to prepare a brief report summarizing project progress within six months.
  • Further reports on project outcomes may be requested in the future to track return on investment.

Program Contacts

    • Administrative contact: Matt Mroz, PhD, OVPR Internal Funding Coordinator. research@uconn.edu;
    • Program Director: Mark Aindow, PhD, Executive Director for Innovation, External Engagement, and Industry Relations. m.aindow@uconn.edu

Innovation Funding Opportunities

Below is a list of funding opportunities for research faculty and students in the areas of Agricultural Sciences, Animal Sciences, Life Sciences, Physical Sciences, Food Sciences, and opportunities for startups.  If you would like to have an opportunity added to the below list, please contact techcomm@uconn.edu.

Agricultural Sciences

Program

Deadline

Description

Bayer Partnering Opportunities Admission Dates Vary Bayer’s vision of #HealthForAll, #HungerForNone drives our need to strengthen innovation capabilities in all areas of agriculture. We know we can’t accomplish this alone, so we’re always interested to hear about novel, early-stage scientific innovations that can contribute to feeding the world without starving the planet. You have our commitment to take a look, match with our R&D priorities and provide you timely feedback.
BASF Admission Dates Vary Join us in our efforts to innovate for a sustainable future: we welcome you to bring in your expertise to help with our ongoing challenges. Beyond that, we regularly offer opportunities for external collaboration in temporary campaigns. Additionally, in our open collaborations, you may find a perfect match with your profile. Take initiative and get in touch with us.
Rolling Admissions Nitrogen is a key requirement for crop growth and building healthy soil supports sustainable crop production. The aim of this project is to identify and validate microbiome health technologies which reduce the reliance on synthetic agrochemicals applied to and/or improve soil health in potato, oat, citrus and corn crops, whilst maintaining yield and quality.
Natural Systems for Reduction in Pesticides, Fungicides, and Fertilizers on Key Crops Rolling Admissions Mondelēz International seeks natural, safe means for increasing growth of key crops such as wheat and cocoa and/or to fight common insect pests and diseases such as fusarium head blight in wheat and Vascular Streak Dieback black pod, pink disease and witches´ broom in cocoa.

 

Program

Deadline

Description

AstraZeneca Preclinical Molecules  Rolling Admissions
Identifying disease targets for active molecules is integral to modern drug discovery. AstraZeneca’s aim is to make high-quality life science research tools available to the external research community to accelerate innovative scientific research. These include antibodies, PROTAC molecules and oligonucleotides that have been developed as part of its drug discovery programs. By combining AstraZeneca’s resources with your insights, we can generate high-quality preclinical data that enhances the understanding of disease pathways and supports the future generation of life-changing medicines.
Merck Business Development Rolling Admissions Open-ended way to connect with Merck’s Business Development team. Use this link to submit any non-confidential information for areas that do not fit neatly into the Merck Investigator Studies Program sections.
AstraZeneca open innovations Rolling Admissions Multiple opportunities.  Please refer to website for details.
Rare Treatment Accelerator (RTA) Rolling Admissions The Rare Treatment Accelerator program connects academic groups, patient groups and early-stage biotechs with Healx to unlock the power of repurposed drugs for rare diseases. Working together, we can quickly turn your research, insights and promising repurposing assets into treatments that will benefit rare disease patients.
Pfizer-Vaccines Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Inflammation and Immunology Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Rare Disease Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 
Pfizer- Internal Medicine Areas of Interest Rolling Admissions Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. 

 

Physical Sciences

Program Deadline Description
IN-PART Global Challenge Campaign Rolling Admissions The research or technology could be anything that provides a positive step forwards for sustainability within plastics, polymers and polymers in liquid formulations (PLFs), by using raw materials that are renewable or sustainable, processes that minimize environmental impacts, and alternatives to plastics that are biodegradable or recyclable. 
Halo Science-Expanded temperature ranges for adhesives Rolling Admissions The sponsor is seeking novel approaches to expand the temperature range of these commercial adhesives to temperatures below 4 C°. Potential solutions from adjacent industries are of significant interest, including novel materials, innovations in manufacturing processes and engineering solutions. Possible partnerships include contract research, providing grant monies, or other forms of investment.

Solutions of interest include:

Materials substitution, multifunctional materials, engineered products, or novel material structures
Curing agents or additives that lower the operational temperature window
Modifications to current manufacturing processes
Coatings, surface treatments, sealing agents, or other post-processing solutions would be considered but are of a lower priority than other methods

BASF Admission Dates Vary Join us in our efforts to innovate for a sustainable future: we welcome you to bring in your expertise to help with our ongoing challenges. Beyond that, we regularly offer opportunities for external collaboration in temporary campaigns. Additionally, in our open collaborations, you may find a perfect match with your profile. Take initiative and get in touch with us.
Shell N/A See website for more details.

Undergraduate Participation in On-Campus Summer 2020 Lab/Field Research

  • The Office of Undergraduate Research and the Office of the Vice President for Research have release guidance on undergraduate participation in on-campus lab/field research during the summer.

    Process to request Undergraduate Student participation in research:

    • The Undergraduate Student should complete and submit the Undergraduate Student Research Request Form. Once submitted, this will be emailed automatically to both the Office of Undergraduate Research and OVPR.
    • The faculty member wanting to add one or more undergraduate students to an approved safety plan should complete and submit the Request to Include Undergraduate Students Form.
    • Once BOTH forms are received, the OVPR will respond with an Approval to both the student and faculty member.
    • For questions or concerns contact the OVPR at ovpr@uconn.edu or Office of Undergraduate Research at our@uconn.edu.

    For more information on safely conducting research during the COVID-19 pandemic, visit the OVPR’s COVID-19 Resource page.

Guidance on Undergraduate Student Participation in Research

Process to request summer Undergraduate Student participation in research. Undergrads will need to be trained on the approved safety plan and have their training documented. The OVPR and Provost’s office will communicate the needed steps for participation in research during the fall semester once the process has been finalized.

  • The Undergraduate Student should complete and submit the Undergraduate Student Research Request Form. Once submitted, this will be emailed automatically to both the Office of Undergraduate Research and OVPR.
  • The faculty member wanting to add one or more undergraduate students to an approved safety plan should complete and submit the Request to Include Undergraduate Students Form.
  • Once BOTH forms are received, the OVPR will respond with an Approval to both the student and faculty member.
  • For questions or concerns contact the OVPR at ovpr@uconn.edu or Office of Undergraduate Research at  our@uconn.edu.

For information about Undergraduate research during the Fall 2020 semester, visit the Office of Undergraduate Research’s website.

Guidance for Reopening Research Involving Human Subjects

This document details the minimum safety procedures that must be in place in order for UConn and UConn Health investigators to be approved by the Office of the Vice President for Research (OVPR) to reopen or initiate new human subjects research. Principal investigators (PIs) must tailor their safety plans to meet the needs of each individual research situation. Environmental Health and Safety (EHS) is available to answer safety related questions from PIs. If you have safety related questions, please email ehs@uconn.edu if your human subject research activities are conducted at the Storrs or regional campuses or call (860) 679-2723 if these activities are taking place at UConn Health.

Guiding principles:

  • Careful planning is required to reduce opportunities for exposure.
  • No individual project involving human subject research activities may be re-started without prior approval from the OVPR.
  • Plan for and operate under the assumption that everyone is an asymptomatic virus carrier.
  • Physical distancing is critical. The recommended minimum distance between individuals is six feet.
  • The smallest number of study personnel possible should conduct approved research until UConn returns to normal operations. This may require the development of cohorts and non-overlapping shifts when scheduling.
  • Research or components of studies that can be conducted without face-to-face interactions or interventions should continue to be conducted remotely.
  • Guidelines will be continually updated as more information about COVID-19 becomes available. Updated guidance will be posted on the OVPR website and communicated to UConn/UConn Health faculty and staff. PIs are responsible for staying informed about changes that will impact human subjects research.
  • If there is a second surge of infection, it may be necessary for research to be ramped down again. During safety planning, consider which studies can be easily halted or delayed. PIs should develop a continuity plan for another potential research ramp-down.
  • Special attention must be paid to risks posed to more vulnerable research subjects (e.g., immunocompromised subjects, older adults with multiple chronic diseases) when evaluating the risks/benefits of subject visits to UConn research facilities.
  • If the facility where the research is being conducted has specific requirements or policies related to COVID-19, then the more restrictive of those or the policies described in this guidance must be followed.

Specific recommendations:

Screening

All participants must be screened for COVID-19 symptoms and exposure. Ideally, participants will be screened prior to entering the research facility (e.g. phone, email, or web-based assessment on the day of the visit) or otherwise being engaged with study interactions or interventions.

Screening Questions

  1. Have you or someone you live with been tested for or diagnosed with COVID-19 in the last four weeks?
  2. Are you experiencing any of the following?
  • Fever (100.4 or higher)
  • Chills
  • New or worsening shortness of breath or difficulty breathing
  • New or worsening cough
  • Muscle or body aches
  • Sore throat
  • Congestion or runny nose
  • Nausea or vomiting
  • Diarrhea
  • New loss of smell or taste

If, such as is currently the case at UConn Health, all individuals entering the facility or building will be screened for COVID-19 symptoms and exposure, then additional screening would not be necessary. If a participant screens positive, then their appointment must be cancelled or rescheduled and the individual should be encouraged to contact their primary care physician and/or the UConn Health COVID Call Center at (860) 679-7560. Temperature screening is not required, but PIs may choose to adopt this measure if it is consistent with campus/building recommendations.

Facial Covering/PPE Requirements

  1. A cloth facial covering or procedure mask must be worn by study personnel and by participants during face-to-face interactions and interventions when:
    • The participant responds NO to COVID-19 Screening AND
    • The participant is located in or from an area or facility with no or only isolated cases AND
    • The interventions are not aerosol generation procedures AND
    • At least six feet of physical distancing will be maintained at all times

Participants and study personnel may wear their own facial coverings. If participants do not provide their own coverings or if their covering fails to cover their nose and mouth, participants must be provided with a procedural mask. Similarly, procedural masks must be available for study personnel. Furthermore, study personnel must keep facial coverings in place regardless of whether participants are present. The use of physical barriers, such as plexiglass, should be considered as additional measures.

  1. Study personnel must wear a procedure mask and face shield during face-to-face interactions and interventions with participants when:
    • The participant responds NO to COVID-19 Screening AND
    • The participant is located in or from an area or facility with no or only isolated cases AND
    • The interventions are not aerosol generation procedures AND
    • At least six feet of physical distancing will NOT be maintained at all times

Participants must continue to wear their own facial coverings or a procedure mask to the fullest extent possible. Participants should remove their mask only briefly (few minutes) if needed for study procedures. If participants do not provide their own covering or if their covering fails to cover their nose and mouth, participants must be provided with a procedural mask. Similarly, procedural masks must be available for study personnel. Furthermore, study personnel must keep facial coverings in place regardless of whether participants are present.

  1. Study personnel must wear an N95, procedure mask, face shield, and gown during face-to-face interactions and interventions with participants when:
    • The participant is known or suspected to have COVID-19 OR
    • The participant is located in or from an area or facility with known or a high likelihood of cases and/or transmission OR
    • Study procedures will not allow the participant to wear a mask or face covering for an extended period of time OR
    • The interventions are aerosol generation procedures

If N95 masks are required, study personnel are required to complete EHS training and certification in order to gain approval for N95 mask usage as outlined in EHS’ Respirator Program Policies, Programs, and Procedures. Medical clearance is also required for study personnel who will be wearing N95 masks. For student personnel, this clearance can be obtained through UConn’s Student Health and Wellness; for other research staff, clearance can be obtained through an Occupational Medicine provider (Storrs and Regional Campus researchers can contact CorpCare in South Windsor). Please contact EHS with any questions pertaining to N95 mask usage.

Relevant Resources

Cleaning/Disinfecting

  1. Research procedure areas, data collection areas, and equipment must be carefully cleaned and disinfected prior to and following use by participants or study personnel. This will include a regular wipe down of shared research equipment and spaces (e.g., desktops) after each participant visit plus a wipe down of shared research equipment and spaces at the end of the day. If participants wish to also wipe down apparatus, they must be provided with disinfectant wipes and encouraged to wear gloves when using them. Please note that any cleaning done by participants does not substitute for the required cleaning by study personnel. If participants are using keyboards, study personnel should put a smooth covering over them. Participants using a shared piece of equipment should also be offered hand sanitizer containing at least 60% alcohol and gloves for optional use during the visit. Participants who choose to wear gloves should be provided with instructions on how to remove and dispose of gloves safely. Hand sanitizer should be available to participants throughout their study visit.

Relevant Resources

  • EHS information sheet on glove removal and disposal
  • CDC poster on glove removal

To allow for cleaning and ventilation, avoid scheduling immediate and consecutive participant visits to research spaces. If more than one clinic or procedural space is available, use a staggered schedule to alternate visits among rooms. Windows should be open when possible to aid in ventilation.

    Other Considerations

    If study personnel are visiting off-campus, non-UConn affiliated facilities (e.g., schools/camps, clinics, etc.), PIs must adhere to the rules for the site. In all cases, the more stringent of the UConn or site guidelines must be followed. Recommendations for study personnel and participants regarding the wearing of facial coverings/masks, maintaining physical distancing whenever possible, and frequent handwashing must always be followed. Research visits to study participants homes should only be conducted if they can be “contactless,” such as deliveries and pickups of samples. Research visits to long-term care facilities and nursing homes must be conducted in accord with state DPH guidelines.

    UConn Storrs/Regional Campus PIs should contact EHS at ehs@uconn.edu with specific questions about research spaces; UConn Health investigators should contact (860) 679-2723.

    References:

    CDC Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19)

     

     

    Guidance for Reopening Research Involving Human Subjects

    The Office of the Vice President for Research (OVPR) has developed new guidance related to resuming human subjects research. The guidance outlines the minimum safety procedures that must be in place in order for UConn and UConn Health investigators to be approved by the OVPR to reopen or initiate new human subjects research. Principal investigators (PIs) must tailor their safety plans to meet the needs of each individual research situation.

    Environmental Health and Safety (EHS) is available to answer safety related questions from PIs. If you have safety related questions, please email ehs@uconn.edu if your human subject research activities are conducted at the Storrs or regional campuses or call (860) 679-2723 if these activities are taking place at UConn Health.

    For more information, visit the OVPR’s COVID-19 Resource page.

    UConn Health General Use PPE for Research Guidelines and Procedures

    The administrative office in each academic department are responsible for the orders to restock department supplies.

    Re-stocking orders can be submitted to PPE@uchc.edu. The email order must be from either the Business Services Manager or Administrative Manager, or if from someone other than the Manager, must copy (CC) the Manager on the order. Orders not from or cc-ing the Manager will be returned. Orders should also provide 3 dates/times when someone will be in the office to receive and sign for the supplies.


    Gloves should continue to be ordered through the Warehouse eportal system. Departments and labs will not be charged for glove orders placed through the Warehouse.

    Departments should plan for up to 72 hours for receipt of supplies from OLM.

    PPE Category Research Order Through
    Restricted Use Yes. Research AVP approval and biosafety, animal, or human subject protocol required. OLM
    Limited Use Yes. Need in research environment as before pandemic and remains chargeable to grants. OLM
    General Use Yes. As long as state and federal guidelines require using face coverings, frequent hand washing, and surface cleaning, these supplies will be provided as needed at no cost to departments or labs. OLM
    Gloves Gloves and paper towels are other supplies that will be in high demand and are necessary to ensure a safe environment. Gloves will be needed for any staff that may be using disinfectant. As long as state and federal guidelines require frequent surface cleaning, gloves will be provided as needed at no cost to departments or labs. Warehouse eportal

    Restricted PPE includes N95 respirators. These materials are only available outside of the clinical areas with approval from a Research AVP.

    Limited Use PPE includes googles, face shields, isolation gowns, hair bouffants, and shoe covers. These materials are not required by state or federal guidelines for the safe return to work, but may be required PPE in a lab setting. These supplies should be ordered through OLM and are chargeable to sponsored projects.

    General Use PPE are required by state and/or federal guidelines for the safe return to work. These supplies include surgical/procedure masks, disinfectant wipes, and hand sanitizer. Supplies will be purchased, stocked, and distributed by OLM for all UCH areas at no cost to departments or labs.

    Guidance on the Preparation of NIH Research Performance Progress Report (RPPRs) and COVID-19 Impacts

    The NIH has issued guidance regarding the preparation of Research Performance Progress Reports (RPPRs) and the reporting of effects of the COVID-19 pandemic on research projects.

    If an investigator is unable to complete a scheduled RPPR by the due date, a notice should be sent to the Grants Management Specialist and the Program Official to let them know that the report will be late and that research outcomes are not available at that time, as well as an outline of when the investigator will be able to include details related to the disruptions to the research efforts. This notification should be completed as soon as possible and should be developed and coordinated with Sponsored Program Services (SPS).  Please be aware that the continuation grant award will be delayed and will not be issued until the RPPR has been received and accepted by the NIH.

    RPPRs that were affected by COVID-19 should include an explanation on the effect that COVID-19 has had on the project, the steps that have been taken to mitigate the disruption, and plans to address these in the coming award period. If certain research outcomes are not available at the time that the RPPR is submitted, those should be outlined and a timeline should be provided as to when they will be addressed.

    Sponsored Program Services is here to assist you with this process and to answer any questions that you may have related to RPPR preparation and submission. Please contact Paul Hudobenko or your Project Officer at UConn Health or your Pre-Award Grant Specialist at Storrs and the regional campuses as early as possible if you have any questions regarding the preparation and submission of RPPRs.   See NOT-OD-20-086 for additional details on late submission.

    Lab Preparedness Guide & Guidance on Submitting NIH RPPRs

    The OVPR’s COVID-19 Resource page has been updated with new guidance on several aspects of ramping up research activity prior to May 20, 2020, including:

    UConn Research Lab Ramp-Up Preparedness Guide

    The OVPR and Environmental Health and Safety have developed a guide to help researchers safely prepare labs to ramp up research activity after May 20, 2020.

    Guidance on the Preparation of NIH Research Performance Progress Report (RPPRs) and COVID-19 Impacts

    Sponsored Program Services has created guidance for investigators related to submission of NIH Research Performance Progress Reports (RPPRs) during the suspension of research due to COVID-19.

    Contact ovpr@uconn.edu with questions.

    Guidance on Animal Rebreeding in the Vivarium and New Animal Orders

    Version 1, May 5, 2020

    To prepare to resume research on May 20, 2020, researchers will be allowed to begin some rebreeding activities and animal orders.

    Effective immediately:

    • Researchers and research staff may work from 1:00 PM to 7:00 PM.
    • The availability and access to procedure rooms is as usual.
    • No more than a total of two people are allowed in a room at a time. Research groups must coordinate room access among themselves to maintain this density.
    • All individuals must have been previously trained and given access to the vivarium. New individuals without previous access or training are not allowed. Individuals do not need to have been previously listed on a Critical Research Infrastructure request form.
    • Everyone must wear a cloth face covering or the mask provided by vivarium at all times.
    • The Facility Manager for the UConn vivarium or Center for Comparative Medicine staff for the UConn Health vivarium must be contacted a day in advance if assistance will be needed, such as needing large numbers of new cage set-ups for breeding, drug orders, veterinary staff help, or other needs.
    • An amendment should be submitted as soon as possible to the IACUC if the animal number on the approved protocol needs to be increased.
    • Research employees who are not feeling well and experiencing any symptoms of illness should remain at home, not report to work, and immediately contact their manager or supervisor. For more information see Guidance on Research Employees Returning to Work.

    Orders for new animals can resume Monday, May 11, 2020.

    Guidance on Expanding Cell Lines, Propagating Plants, and Initiating Rebreeding of Non-Vivarium Housed Animals/Insects

    Version 1, May 5, 2020

    To prepare to resume research on May 20, 2020, researchers will be allowed to begin some other activities, such as expanding cell lines, propagating plants, and rebreeding of non-vivarium houses animals/insects.

    Effective Immediately:

    • Researchers and research staff may work from 6:00 AM to 7:00 PM, with a limit of no more than four hours per day.
    • No more than two people are allowed in a room/area at a time. Each Research Group must self-coordinate room/area access. For large areas such as large shared labs or research spaces, the greenhouses and fields, personnel density may be more than two, but must ensure at least six feet distancing in all directions for all individuals.
    • Only individuals who have been previously approved on a Critical Research Infrastructure request form are allowed. CRI requests should be amended as needed.
    • Everyone must wear a cloth face covering at all times unless doing so would pose a risk to an individual’s health or safety because of a medical condition.
    • People must come in, do what is necessary, and then leave. No “hanging out,” initiating research activities or experiments, doing other tasks, etc. is allowed.
    • Each researcher is responsible for cleaning/disinfecting all areas where they have worked upon completion.
    • Suspension of research ramp-up may occur at any time depending on circumstances and state guidelines. This could require an immediate discontinuation of all work. All researchers must bear this in mind when considering which research reagents to re-initiate.
    • Research employees who are not feeling well and experiencing any symptoms of illness should remain at home, not report to work, and contact their manager or supervisor. For more information see Guidance on Research Employees Returning to Work.